- $2.46bn
- $2.40bn
- $4.43bn
- 93
- 56
- 19
- 56
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,988 | 2,940 | 3,766 | 5,029 | 4,427 |
Cost of Revenue | |||||
Gross Profit | 2,299 | 2,273 | 3,134 | 4,205 | 3,723 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,925 | 2,842 | 3,489 | 4,634 | 4,255 |
Operating Profit | 63.8 | 98.3 | 277 | 395 | 173 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 51.5 | 92.5 | 273 | 388 | 187 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40 | 71.1 | 210 | 295 | 142 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 40 | 71.1 | 214 | 298 | 195 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 40 | 71.1 | 214 | 298 | 195 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.12 | 2.59 | 7.58 | 11.2 | 7.01 |
Dividends per Share |